Search Results - cancer

4 Results Sort By:
Panaxynol as a new agent for cancer prevention and treatment
Reference #: 01618 The University of South Carolina is offering licensing opportunities for Panaxynol as a new agent for cancer prevention and treatment Background: National costs for cancer care were estimated to be $208.9 billion in 2020; particularly for colorectal cancer (CRC), the economic burden in the U.S. is estimated to be over $24 billion...
Published: 9/19/2023   |   Inventor(s): Angela Murphy, Lorne Hofseth
Keywords(s): cancer, cancer prevention, cancer treatment, Colon cancer, Natural product, polyps
Category(s): Biomedical and Life Sciences, Health Sciences
Nanoparticle for the remodeling of cancer-associated fibroblast
Reference #: 01513 The University of South Carolina is offering licensing opportunities for Nanoparticle for the remodeling of cancer-associated fibroblast Background: The biomimetic enzyme activity of the cerium oxide nanoparticle (CeNP) prefers ultrasmall particle size and bare surface. Unfortunately, those two features are not favorable for its...
Published: 1/19/2024   |   Inventor(s): Peisheng Xu
Keywords(s): cancer, cancer metastasis, cancer treatment, cancer-associated fibroblast, tumor microenvironment remodeling
Category(s): Nanotechnology, Health Sciences, Biomedical and Life Sciences
Targeting Treatment For ADAM30 In Pathological Cells
Reference #: 01462 The University of South Carolina is offering licensing opportunities for Targeting treatment for ADAM30 in pathological cells Background: The treatment options for vascular malformations include conservative management, drug treatment, interventional radiology, laser therapy, excisional surgery and psychological treatment. However,...
Published: 12/13/2023   |   Inventor(s): Wenbin Tan, Elaine Taine, Hui Wang, Vi Nguyen, Xialing Cao
Keywords(s): a disintegrin and metalloprotease (ADAM), antibody, biomarker, cancer, inhibitor, vascular malformation
Category(s): Health Sciences, Biomedical and Life Sciences
Carrier-Free Curcumin Nanoparticle for EGFR Positive Cancer Therapy
Reference #: 01472 The University of South Carolina is offering licensing opportunities for Carrier-free curcumin nanoparticle for EGFR positive cancer therapy Background: Due to their small size and large surface area, drug nanoparticles show great promise in improving drug delivery in patients. Invention Description: Most nanoparticle based...
Published: 2/1/2024   |   Inventor(s): Peisheng Xu
Keywords(s): cancer, carrier-free, curcumin, EGFR receptor, erlotinib, nanoparticle, Nanotechnology
Category(s): Health Sciences, Biomedical and Life Sciences, Nanotechnology
© 2024. All Rights Reserved. Powered by Inteum